These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 19547910)

  • 1. Animal insulin therapy induces a biased insulin antibody response that persists for years after introduction of human insulin.
    Oak S; Phan TH; Gilliam LK; Hirsch IB; Hampe CS
    Acta Diabetol; 2010 Jun; 47(2):131-5. PubMed ID: 19547910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding characteristics and crossreactivity of insulin autoantibodies and insulin antibodies directed to three different insulin molecules.
    Jaeger C; Winter S; Eckhard M; Hardt P; Brendel MD; Bretzel RG
    Acta Diabetol; 2008 Sep; 45(3):191-4. PubMed ID: 18493700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal epitope analysis of insulin-binding antibodies in type 1 diabetes.
    Hall TR; Thomas JW; Padoa CJ; Torn C; Landin-Olsson M; Ortqvist E; Hampe CS
    Clin Exp Immunol; 2006 Oct; 146(1):9-14. PubMed ID: 16968392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The measurement of insulin antibodies and insulin autoantibodies by enzyme-linked immunosorbent assay using recombinant human insulin antigen and its clinical application].
    Ueno H; Nishiyama A; Akita M; Watanabe T; Fukumura Y; Nagashima K; Ushijima Y; Kobayashi I
    Nihon Naibunpi Gakkai Zasshi; 1994 Aug; 70(6):585-96. PubMed ID: 7958108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies to insulin, insulinoma-associated antigen-2, and zinc transporter 8 improve the prediction of early insulin requirement in adult-onset autoimmune diabetes.
    Kawasaki E; Nakamura K; Kuriya G; Satoh T; Kuwahara H; Kobayashi M; Abiru N; Yamasaki H; Eguchi K
    J Clin Endocrinol Metab; 2010 Feb; 95(2):707-13. PubMed ID: 20061424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin antibody response to a short course of human insulin therapy in women with gestational diabetes.
    Balsells M; Corcoy R; Mauricio D; Morales J; García-Patterson A; Carreras G; Puig-Domingo M; de Leiva A
    Diabetes Care; 1997 Jul; 20(7):1172-5. PubMed ID: 9203458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody response to inhaled insulin in patients with type 1 or type 2 diabetes. An analysis of initial phase II and III inhaled insulin (Exubera) trials and a two-year extension trial.
    Fineberg SE; Kawabata T; Finco-Kent D; Liu C; Krasner A
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3287-94. PubMed ID: 15741258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent reoccurrence of hypoglycemia in a type 2 diabetic patient with insulin antibodies.
    Zhao TY; Li F; Xiong ZY
    Mol Diagn Ther; 2010 Aug; 14(4):237-41. PubMed ID: 20799766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of long-term exposure to insulin lispro on the induction of antibody response in patients with type 1 or type 2 diabetes.
    Fineberg SE; Huang J; Brunelle R; Gulliya KS; Anderson JH
    Diabetes Care; 2003 Jan; 26(1):89-96. PubMed ID: 12502663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin autoantibodies and immune response to human insulin therapy in 24 type 1 (insulin-dependent) diabetic children: superiority of radio binding assay over solid phase assay.
    de Beaufort CE; Sodoyez JC; Koch M; Bruining GJ; Sodoyez-Goffaux F
    Diabetes Res Clin Pract; 1993 Jul; 21(1):19-24. PubMed ID: 8253017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-titer autoantibodies against glutamic acid decarboxylase plus autoantibodies against insulin and IA-2 predicts insulin requirement in adult diabetic patients.
    Kasuga A; Maruyama T; Nakamoto S; Ozawa Y; Suzuki Y; Saruta T
    J Autoimmun; 1999 Mar; 12(2):131-5. PubMed ID: 10047433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of anti-insulin antibody in patients with type 1 diabetes mellitus treated with continuous subcutaneous insulin infusion or multiple daily insulin injections therapy.
    Sahin SB; Cetinkalp S; Ozgen AG; Saygili F; Yilmaz C
    Acta Diabetol; 2010 Dec; 47(4):325-30. PubMed ID: 20842389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutamic acid decarboxylase antibodies (GADA) is the most important factor for prediction of insulin therapy within 3 years in young adult diabetic patients not classified as Type 1 diabetes on clinical grounds.
    Törn C; Landin-Olsson M; Ostman J; Scherstén B; Arnqvist H; Blohmé G; Björk E; Bolinder J; Eriksson J; Littorin B; Nyström L; Sundkvist G; Lernmark A
    Diabetes Metab Res Rev; 2000; 16(6):442-47. PubMed ID: 11114103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure to exogenous insulin promotes IgG1 and the T-helper 2-associated IgG4 responses to insulin but not to other islet autoantigens.
    Füchtenbusch M; Kredel K; Bonifacio E; Schnell O; Ziegler AG
    Diabetes; 2000 Jun; 49(6):918-25. PubMed ID: 10866043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the idiotypes of insulin antibodies as markers for remission in Type 1 diabetes.
    Devendra D; Galloway TS; Horton SJ; Wilkin TJ
    Diabet Med; 2004 Dec; 21(12):1316-24. PubMed ID: 15569135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Perinatal outcomes in pregnant women with diabetes mellitus and different level of autoantibodies to insulin and its receptors].
    Protsenko AM; Budykina TS; Morozov SG; Rybakov AS; Gribova IE; Protsenko AN
    Patol Fiziol Eksp Ter; 2010; (2):18-22. PubMed ID: 20804070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of insulin antibodies by Surface Plasmon Resonance in two clinical cases: brittle diabetes and insulin autoimmune syndrome.
    Trabucchi A; Iacono RF; Guerra LL; Faccinetti NI; Krochik AG; Arriazu MC; Poskus E; Valdez SN
    PLoS One; 2013; 8(12):e84099. PubMed ID: 24386337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular and humoural autoimmunity markers in type 2 (non-insulin-dependent) diabetic patients with secondary drug failure.
    Zavala AV; Fabiano de Bruno LE; Cardoso AI; Mota AH; Capucchio M; Poskus E; Fainboim L; Basabe JC
    Diabetologia; 1992 Dec; 35(12):1159-64. PubMed ID: 1478368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-mediated insulin resistance treated by cessation of insulin administration.
    Hara K; Tobe K; Uchigata Y; Nakazono M; Yasuda K; Terauchi Y; Iwamoto Y; Akanuma Y; Kimura S; Kadowaki T
    Intern Med; 2000 Feb; 39(2):143-5. PubMed ID: 10732832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies in children with type 2 diabetes mellitus.
    Umpaichitra V; Banerji MA; Castells S
    J Pediatr Endocrinol Metab; 2002 Apr; 15 Suppl 1():525-30. PubMed ID: 12017227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.